Search

everythinglearnresearchcommunity

for

Search:↓

The new adapalene formulation using TyroSpheres is more effective and less irritating for acne treatment.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Dupilumab for skin problems might reactivate hair loss in some patients.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Apremilast shows promise for several skin conditions but needs more research.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Aqueous dispersion resin is safe to inhale at levels below 30 mg/m³.

Intradermal testing can better detect corticosteroid allergies than patch testing.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Exosomes show promise as effective treatments for autoimmune skin diseases with fewer side effects.

Multicomponent crystals in microneedles improve drug delivery for hair loss treatment.

Mixed coconut oil/solvent is suitable for cyproterone acetate injections, but more safety checks are needed.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Poor air quality increases the risk of atopic dermatitis in Taiwan.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

The oral contraceptive with ethinyl estradiol and chlormadinone acetate is effective in treating moderate acne.

An 8-year-old boy with hair loss had hair regrowth and responded well to clobetasol propionate treatment.